Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

2.

Co-receptors for HIV-1 entry.

Moore JP, Trkola A, Dragic T.

Curr Opin Immunol. 1997 Aug;9(4):551-62. Review.

PMID:
9287172
4.

Two distinct CCR5 domains can mediate coreceptor usage by human immunodeficiency virus type 1.

Doranz BJ, Lu ZH, Rucker J, Zhang TY, Sharron M, Cen YH, Wang ZX, Guo HH, Du JG, Accavitti MA, Doms RW, Peiper SC.

J Virol. 1997 Sep;71(9):6305-14.

6.

Macrophage tropism: fact or fiction?

Stent G, Joø GB, Kierulf P, Asjö B.

J Leukoc Biol. 1997 Jul;62(1):4-11.

PMID:
9225986
7.

Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses.

Vodicka MA, Goh WC, Wu LI, Rogel ME, Bartz SR, Schweickart VL, Raport CJ, Emerman M.

Virology. 1997 Jun 23;233(1):193-8.

8.

Evolution of HIV-1 coreceptor usage through interactions with distinct CCR5 and CXCR4 domains.

Lu Z, Berson JF, Chen Y, Turner JD, Zhang T, Sharron M, Jenks MH, Wang Z, Kim J, Rucker J, Hoxie JA, Peiper SC, Doms RW.

Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6426-31.

9.

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro.

Wu L, Paxton WA, Kassam N, Ruffing N, Rottman JB, Sullivan N, Choe H, Sodroski J, Newman W, Koup RA, Mackay CR.

J Exp Med. 1997 May 5;185(9):1681-91.

10.

Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity.

Gosling J, Monteclaro FS, Atchison RE, Arai H, Tsou CL, Goldsmith MA, Charo IF.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5061-6.

11.

Coreceptors: implications for HIV pathogenesis and therapy.

Moore JP.

Science. 1997 Apr 4;276(5309):51-2. Review. No abstract available.

PMID:
9122710
12.

Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.

Edinger AL, Amedee A, Miller K, Doranz BJ, Endres M, Sharron M, Samson M, Lu ZH, Clements JE, Murphey-Corb M, Peiper SC, Parmentier M, Broder CC, Doms RW.

Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4005-10.

14.

Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.

Simmons G, Clapham PR, Picard L, Offord RE, Rosenkilde MM, Schwartz TW, Buser R, Wells TN, Proudfoot AE.

Science. 1997 Apr 11;276(5310):276-9.

15.

Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.

Carroll RG, Riley JL, Levine BL, Feng Y, Kaushal S, Ritchey DW, Bernstein W, Weislow OS, Brown CR, Berger EA, June CH, St Louis DC.

Science. 1997 Apr 11;276(5310):273-6.

16.

Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.

Rana S, Besson G, Cook DG, Rucker J, Smyth RJ, Yi Y, Turner JD, Guo HH, Du JG, Peiper SC, Lavi E, Samson M, Libert F, Liesnard C, Vassart G, Doms RW, Parmentier M, Collman RG.

J Virol. 1997 Apr;71(4):3219-27.

17.

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression.

Michael NL, Chang G, Louie LG, Mascola JR, Dondero D, Birx DL, Sheppard HW.

Nat Med. 1997 Mar;3(3):338-40.

PMID:
9055864
18.

HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5.

Farzan M, Choe H, Martin KA, Sun Y, Sidelko M, Mackay CR, Gerard NP, Sodroski J, Gerard C.

J Biol Chem. 1997 Mar 14;272(11):6854-7.

19.

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR.

Proc Natl Acad Sci U S A. 1997 Mar 4;94(5):1925-30.

20.

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals.

Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR.

J Exp Med. 1997 Feb 17;185(4):621-8.

Supplemental Content

Support Center